AAX Biotech will be attending Festival of Biologics 2026

AAX Biotech is attending Festival of Biologics Basel, 13-15 October at Messe Basel!

Our CEO/CSO Daniel X. Johansson is excited to present a poster on Opti-mAb®, our cutting-edge technology that solves scFv instability - one of the most persistent challenges in antibody therapeutics. Resulting in less aggregation and improved stability, Opti-mAb improves the therapeutic performance of next-generation modalities, such as bi- and multispecific antibodies, as well as CAR-Ts.

Find Daniel at poster #1: “Opti-mAb: Enabling Next-Generation Antibody Therapeutics”.

Additionally, our partner evitria AG will be presenting their hot-off-the-press Opti-mAb® evaluation results in poster #56. We’re excited and thankful for this collaboration and look forward to seeing more people access Opti-mAb® through evitria.

Will you be in Basel and want to hear more? Book a meeting with Daniel or chat with him over coffee!